38
Key features 384 or 768 cells in parallel (384 or 768 amplifier) 384 pipettor head 85 % success rates routinely obtained Excellent results with voltage-gated & ligand- gated ion channels Modular approach – easy upgrade & integration Single- and multi-hole recording substrates Nanion Technologies SyncroPatch 384PE - Patch Clamp gone HTS! Dr. Markus Rapedius, Application Scientist

Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

Key features

384 or 768 cells in parallel (384 or 768 amplifier)

384 pipettor head

85 % success rates routinely obtained

Excellent results with voltage-gated & ligand-

gated ion channels

Modular approach – easy upgrade & integration

Single- and multi-hole recording substrates

Nanion Technologies

SyncroPatch 384PE - Patch Clamp gone HTS!

Dr. Markus Rapedius, Application Scientist

Page 2: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

Measure More

Membrane

The Port-a-Patch. The world’s smallest patch clamp rig.

• Fast access to high quality patch

clamp data

• Quick evaluation of cells and

compounds

• Novel experimental possibilities

The Patchliner. Because quality does matter.

• Unlimited experimental freedom

• Best of all worlds: throughput,

performance and versatility

• Press one button and walk away:

- 48 cells in one run

The SyncroPatch 96. Get more throughput.

• Cost-efficient ion channel

screening

• Ligand- and voltage-gated

channels

• High throughput and high data

quality

The Vesicle Prep Pro. Liposomes made easy.

• Quick and easy formation of

GUVs

• Temperature control

• Stable bilayers for ephys

recordings

The Orbit 16. Instant bilayer – just add protein.

• 16 parallel bilayers

• Low noise, high bandwidth

recordings

• Compatible with your existing

amplifier

The SURFE2R. Catch the wave for transporters.

• In-depth analysis of transporter

protein activity and function

• Compatible with diverse

membrane sources

• Multiple targets investigated with

one sensor

Smart tools for ion channel and transporter research and screening

12 years of patch clamping - and more to come

The CardioExcyte 96. Bump up your safety screening.

• Ultra-precise impedance

measurements

• Real time access to beating

parameters

• Quick experiments and long term

observations

Nanion:

Page 3: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

Stand alone machines

Higher throughput

Patch Clamping

Integration in HTS?

48

8

96

384

16

The PatchEngine – modular, compact and accessible

The PatchEngine –

the core of the SyncroPatch 384PE

Page 4: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

Components:

Biomek FX with a 384 pipetting head

including gripper

1-2 SyncroPatch 384PE Modules

1 - 2 x 384 channel amplifier

SyncroPatch 384 software

NPC-384 borosilicate chip

Temperature controlled cell hotel

Integrated Barcode scanner

Optional 8 channel pipetting head

(Screen 100% of all compounds)

SyncroPatch 384PE – Set-up overview using the Biomek FX robot

Open design allows for seamless integration into robotic HTS-highways

Page 5: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

Available as single and multi-hole borosilicate plates:

Single-hole substrate: Four-hole

substrate:

SyncroPatch 384 PE – Consumables NPC-384

Page 6: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

84 % > 500 Mohm

Wellplate overview Close up

selectable traces

Experiment

statistics

One well highlighted

Current-Voltage (I/V) Relationship of hERG (CHO)

Page 7: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

84 % > 500 Mohm

Current-Voltage (I/V) Relationship of hERG (CHO)

Page 8: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

0

50

100

150

200

250

<5 5-10 10-15 15-20 20-25 >25

co

un

ts

C slow [pF]

0

50

100

150

200

250

300

<5 5-10 10-15 15-20 20-25

co

un

ts

R series [MΩ]

0

20

40

60

80

100

disabled (no

catch)

<100 100 - 500 >500c

ells

[%]

R seal [MΩ]

Start of experiment

End of experiment

Success rates of hERG expressed in CHO cells

Page 9: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

Chip load &

priming

1-2 Control washes +

3 cmpd concentrations

8 – 12 minutes 5 minutes 2 minutes

Exp end &

Chip unload

Total experiment length for 4 – 5 additions: 15 – 20 minutes

Experiment length is exposure time dependent.

Experiment overview

SyncroPatch 384 PE – quick priming and short experiments

Page 10: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

The SyncroPatch 384 PE has been validated with:

• cell lines: CHO, HEK, LTK, 1321 N1, NCL-SG3, Jurkat and RBL-1

• Cor.4U® iPSC Derived Human Cardiomyocytes

• ion channels:

• voltage-gated: hERG, Nav1.1, 1.5, 1.7, Kv1.3, Cav3.2

• ligand-gated: GABAA (α1,β2,γ2), Glycine (α1), GluA2,

P2X3, TRPA1, ASIC3, GluN1/N2B

• other: TMEM16a, Kir6.2-SUR2A, Kir2.1

SyncroPatch 384 PE – Assay compatibility examples

Page 11: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

Voltage-gated channels (e.g. hNav 1.7)

Page 12: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

hNav1.7 block by Tetracaine (5 µM, 50 µM and 500 µM )

CHO-hNav1.7 cells were kindly provided by Anaxon

Success rate: 92.4 %

Page 13: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

SyncroPatch 384PE Solution Application: Mix and Read

for Voltage gated channels

cu

rre

nt

time

0

-

+

Page 14: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

Exp length: 15 minutes

Success rate: 86.2 %

Tetracaine IC50: 49.6µM

hNav1.7 block by Tetracaine (5 µM, 50 µM and 500 µM)

CHO-hNav1.7 cells were kindly provided by Anaxon

Page 15: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

read-out at 3 different pulses

Fast and easy analysis – more complex protocols

control 5 µM 15 µM 50 µM Tetracaine

control

5 µM

15 µM

50 µM

Page 16: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

Effect of 0, 5, 15 and 50 mM Tetracaine

on 1st, 2nd and 10th pulse

DataControl 384: A fast and easy way of data analysis

Page 17: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

Effect of 0, 5, 15 and 50 mM Tetracaine

on 1st, 2nd and 10th pulse

DataControl 384: A fast and easy way of data analysis

Tetracaine

1st pulse IC50 = 41.8 µM

2nd pulse IC50 = 9.9 µM

10th pulse IC50 = 3.0 µM

Page 18: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

Current amplitude stability Seal stability

SyncroPatch 384 PE – High Quality Measurements

Inactivation stability (C1/C2)

Page 19: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

TRPA1

Page 20: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

TRPA1 expressed in HEKcells

The cells were kindly provided by Millipore

TRPA1 currents were initially activated by Supercinnamaldehyde (SCMA; 5 μM) and then blocked by the specific inhibitor A-967079. 242 of 283 cell were used for the IC50 analyses

Page 21: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

TRPA1 expressed in HEKcells

74,2 % > 500 Mohm

The cells were kindly provided by Millipore

Page 22: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

Ligand gated channels (e.g. hGABAA)

Page 23: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

Stacked Application of solutions

for ligand-gated channels

cu

rre

nt

time

0

-

+

Page 24: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

Repeated exposure of GABA

3x application of 2µM GABA -> stable and reproducable responses

Page 25: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

Fast ligand gated channels (e.g. hGluA2)

Page 26: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

Time course of stacked application

Repeated activation of HEK-hGluA2 by 300 µM Glutamate

Activation by 100 µM, 300 µM and 1 mM Glutamate

Zooming in shows an activation below 10 ms

Page 27: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

Potassium currents through endogenous Kir 2.1-channels in RBL cells

Exp length: 15 minutes

Success rate: 90.1 %

Exchange rate: <50 ms

Fluidic Properties tested on RBL cells

Page 28: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

Allosteric Modulation

Page 29: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

1 µM GABA + 100 µM Pentobarbital

Allosteric Modulation of HEK-GABA by Pentobarbital

1 µM GABA

The amplitude of the allosteric modulation can be normalized to the original

amplitude of the agonist (GABA) within every individual cell.

Page 30: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

1 µM GABA

1 µM GABA + 1 µM Pentobarbital

1 µM GABA + 10 µM Pentobarbital

1 µM GABA + 100 µM Pentobarbital

1 µM GABA + 1mM Pentobarbital

1 µM GABA + 30 µ M GABA

1 µM GABA

1 µM GABA

1 µM GABA

1 µM GABA

1 µM GABA

1 µM GABA

Page 31: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

SyncroPatch 384 PE – Allosteric Modulation, fast and easy

HEK Gaba, 2µM GABA + 10 µ M

Page 32: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

Ongoing project: HTS screening of Cor.4U cells!

Page 33: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

384 scd cardiomyocytes (Cor.4U) in parallel!

Ongoing project: HTS screening of Cor.4U cells!

Page 34: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

Ongoing project: HTS screening of Cor.4U cells!

Page 35: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

384 scd cardiomyocytes (Cor.4U) in parallel!

Page 36: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening

Key features

384 or even 768 cells in truly parallel & modular approach

Giga-seal recordings of individually clamped cells

Up to 25,000 data points per day

85 % success rates routinely obtained

Extremely low cost per data point

Validated for diverse ion channels targets

Integrates easily into an HTS environment

Already installed in pharma, biotech, CRO + academia!

Page 37: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

Foreign Branches: USA China Japan

Page 38: Nanion Technologies - Hamamatsu Photonics · The SyncroPatch PE (PatchEngine) a Revolutionary Instrument for APC-based Ion Channel Drug Screening Key features 384 or even 768 cells

Nanion Customer Reference

- a global customer base distributed between industrial and academic laboratories

Companies:

• Abbott

• Almirall Prodesfarma

• AstraZeneca

• Amgen

• Aurigene Discovery Technologies,

Ltd.

• Axiogenesis

• Bayer

• Bionomics

• Boehringer Ingelheim

• Bristol-Myers Squibb

• Center for New Drug Safety

Evaluation and Research (NCDSER),

• Chromocell

• conoGenetix biosciences GmbH

• Evotec

• Genionics

• GlaxoSmithKline

• Grünenthal

• Hofman La Roche

• Hydra Biosciences

• Japanese Tobacco

• Lupin Limited

• Merck

• Merch Serano

• Novartis

• Novo Nordisk

• Nycomed

• Ono Pharmaceutical

• Orion Pharma

• Pfizer

• Pierre Fabre

• Regeneron Pharmaceuticals

• Rytmion

• Sanofi-Aventis

• Shinogi

• Siena Biotech

• SK Holding, Co Ltd

• Sundia MediTech Company, Ltd.

• Suven Life Sciences Ltd, Hyderabad,

India

• Syngenta

• UCB Pharma

• Vertex Pharmaceuticals

• Vimta Labs Life Sciences,

Hyderabad, India

• Wyeth

• Xention

Research institues and universites:

• Cambridge University, Cambridge, UK

• Charité - Universitätsmedizin Berlin,

Germany

• Consiglio Nazionale delle Ricerche,

Povo (Trento), Italy

• Copenhagen University, Denmark

• Cornell University, Geneva, NY, USA

• Eberhard Karls Universität Tübingen,

Germany

• FMP, Berlin, Germany

• Forschungszentrum Caesar, Bonn,

Germany

• Forschungszentrum Jülich GmbH, Jülich,

Germany

• Friedrich-Schiller-Universität Jena,

Germany

• Georg-August-Universität Göttingen,

Germany

• Griffith University, Nathan, Australia

• GSF - Forschungszentrum für Umwelt

und Gesundheit, GmbH, Neuherberg,

Germany

• Hasselt University, Diepenbeek ,Belgium

• Hertie Institute for Clinical Brain

Research, Germany

• Howard Florey Institute, USA

• Howard Hughes Medical Institute,

Ashburn, VA, USA

• Institute of Genomics and Integrative

Biology, Delhi, India

• IPBS-CNRS, Tolouse, France

• Istituto Italiano di Tecnologia, Genova,

Italy

• Jacobs University, Bremen, Germany

• JNCASR, Bangalore, India

• Julius von Sachs Institut, Würzburg,

Germany

• Karolinska Institute, Stockholm, Sweden

• Kiserleti Orvostudomanyi Kutatointezet,

Budapest, Hungary

• Korea Institute of Science and

Technology (KIST), Seoul, South Korea

• Laboratorio Especial de Toxinologia

Aplicada CAT-CEPID, Sao Paolo, Brazil

• Ludwig Maximillian Universität,

München, Germany

• Lund University, Lund, Sweden

• Max Planck Institut, Göttingen,

Germany

• Medizinische Hochschule Hannover,

Germany

Research institues and universites: (cont.)

• University of Michigan, Ann Arbor, MI,

USA

• Università degli Studi di Napoli -

Federico II, Napoli, Italy

• University of North Carolina, Wilmington,

NC, USA

• University of Queensland, Brisbane,

Australia

• University of Rochester, NY, USA

• University of Tennessee Health Science

Center, USA

• University of Valladolid and Spanish

National Research Council (CSIC),

Valladolid, Spain

• University of Washington, USA

• University of Wisconsin, Madison, WI,

USA

• Universität Zürich, Switzerland

• Universitatea Lucian Blaga din Sibiu,

Romania

• Universität Augsburg, Germany

• Universität Freiburg, Germany

• Universität für Bodenkultur, Wien, Austria

• Universität Heidelberg, Germany

• Universität Hohenheim, Germany

• Universität Osnabrück, Germany

• Vanderbilt Medical School, Nashwille,

TN, USA

• Virginia State University, Blacksburg, VA,

USA

• X-Lab, Göttingen, Germany

• Yale University, New Haven, CT, USA

• Inje University, Busan, South Korea

Research institues and universites: (cont.)

• Nanjing University, Nanjing, China

• Nanyang Technological University,

Singapore

• National University of Singapore,

Singapore

• National Center for New Drug Safety

Evaluation and Research (NCDSER),

Shanghai, China

• National Heart Center, Singapore

• National Jewish Medical and Research

Center, Denver, CO, USA

• NIH/NINDS, Bethesda, MD, USA

• NIST, Gaithersburg, MD, USA

• New York University, NY, USA

• RMIT University, Bundoora, Australia

• Ruhr-Universität Bochum, Germany

• Shanghai Institute of Materia Medica,

Shanghai, China

• Simon Fraser University, Burnaby,

Canada

• Southampton General Hospital,

Southampton, UK

• Stiftung Alfred-Wegener-Institut für

Polar- und Meeresforschung,

Bremerhaven, Germany

• Syracuse Univerity, NY, USA

• Technische Universität Ilmenau,

Germany

• Technische Universität Darmstadt,

Germany

• Technische Universiät München,

Germany

• Uppsala University, Uppsala, Sweden

• UNESCO, Bahía Blanca, Argentina

• Universidade Federal de Sao Paulo,

Brazil

• Università degli Studi di Genova, Italy

• Universitatea Lucian Blaga Din Sibiu,

Romania

• University of California, Los Angeles,

CA, USA

• University of California, San Diego, CA,

USA

• University of Cambridge, UK

• University of Cincinnati, OH, USA

• University of Groningen, the

Netherlands

• University of Leeds, UK

• Universidade de Lisboa, Portugal

Companies:

• Abbott

• Almirall Prodesfarma

• AstraZeneca

• Amgen

• Aurigene Discovery Technologies,

Ltd.

• Axiogenesis

• Bayer

• Bionomics

• Boehringer Ingelheim

• Bristol-Myers Squibb

• Center for New Drug Safety

Evaluation and Research (NCDSER),

• Chromocell

• conoGenetix biosciences GmbH

• Evotec

• Genionics

• GlaxoSmithKline

• Grünenthal

• Hofman La Roche

• Hydra Biosciences

• Japanese Tobacco

• Lupin Limited

• Merck

• Merch Serano

• Novartis

• Novo Nordisk

• Nycomed

• Ono Pharmaceutical

• Orion Pharma

• Pfizer

• Pierre Fabre

• Regeneron Pharmaceuticals

• Rytmion

• Sanofi-Aventis

• Shinogi

• Siena Biotech

• SK Holding, Co Ltd

• Sundia MediTech Company, Ltd.

• Suven Life Sciences Ltd, Hyderabad,

India

• Syngenta

• UCB Pharma

• Vertex Pharmaceuticals

• Vimta Labs Life Sciences,

Hyderabad, India

• Wyeth

• Xention